Financials
- Market Capitalization 22.02 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.41
市销率
3.86
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 517 | ROIV Roivant Sciences Ltd. - Common Shares | 33.35 USD | -3.58% | -5.31% | -17.94% | +82.14% | 24.09 B USD | ||
| 526 | UTHR United Therapeutics Corporation - Common Stock | 543.40 USD | -1.22% | +0.18% | +7.25% | +24.14% | 23.31 B USD | ||
| 558 | BNTX BioNTech SE - American Depositary Shares | 89.01 USD | -7.13% | -5.77% | -12.74% | -12.26% | 21.36 B USD | ||
| 564 | INSM Insmed Incorporated - Common Stock | 96.79 USD | -1.80% | -6.84% | -25.26% | -40.27% | 21.14 B USD |